Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys
- 1 August 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (8) , 1269-1270
- https://doi.org/10.1128/aac.32.8.1269
Abstract
A human intravenous immunoglobulin preparation containing neutralizing antibodies to respiratory syncytial virus (RSV) was utilized for intratracheal and topical treatment of laboratory-induced RSV infections in owl monkeys (Aotus trivirgatus). Topically administered antibodies induced significant reductions in RSV shedding in the lower respiratory tract.This publication has 8 references indexed in Scilit:
- Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young childrenAntimicrobial Agents and Chemotherapy, 1987
- Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton ratsJournal of Virology, 1987
- Studies of Passive Immunotherapy for Infections of Respiratory Syncytial Virus in the Respiratory Tract of a Primate ModelThe Journal of Infectious Diseases, 1985
- Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton ratVirus Research, 1985
- Measurement of monoclonal antibody concentrations in hybridoma cultures: Comparison of competitive inhibition and antigen capture enzyme immunoassaysJournal of Immunological Methods, 1983
- Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutantsInfection and Immunity, 1979